COVID-19 Hospitalization 23 Times Higher for Unvaccinated During Omicron Surge
The COVID-19 Omicron variant may cause milder disease than the Delta variant, but its rapid spread in Los Angeles County still singled out unvaccinated Angelinos.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 3, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Topline Phase 3 Data for NASH Candidate Resmetirom Set Promising Stage
Adverse events seen with resmetirom were similar across dose and placebo groups and there were "significant reductions" seen in liver fat, LDL-C, and ApoB.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 2, 2022
Barriers to Intensifying Insulin in T2D Management: An Interview on Clinical Inertia
Type 2 diabetes patients-and their PCPs-may have trouble moving to basal + mealtime insulin from basal insulin alone. Endocrinologist Brian Levy, MD, offers insights.
Tezepelumab Reduces Exacerbations in Patients with Severe Asthma Regardless of Season
New data from the phase 3 NAVIGATOR trial demonstrate superior efficacy of tezepelumab to reduce asthma exacerbations in severe disease year round.
Workplace Pesticide Exposure Tied to Higher Risk of COPD, Suggests New Study
Occupational exposure to pesticides was linked to an increased risk of COPD in a large UK study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 1, 2022
Omicron Subvariant BA.2: What We Know Now
Known as BA.2, the new Omicron subvariant is now circulating at low levels in the US. What can you tell your patients? Here's what we know, now.
Leading Risk Factors Associated with Childhood Obesity: A Primer for Practitioners
How do low socioeconomic status and adverse childhood experiences tie into pediatric obesity? Here, an overview for practitioners.
Hospitalization for Hypertensive Crises Doubles in US While Overall Hypertension Control Improves
Hospitalization rates for men with hypertensive crisis were higher vs for women, but odds of death during hospitalization decreased for both sexes between 2004-2014.
Those at Greatest Genetic Risk for Heart Disease May Benefit Most from Cardiovascular Health Recommendations
Following AHA's Life's Simple 7 guidelines can reduce the risk of coronary heart disease despite genetic predisposition, according to new study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 31, 2022
USPSTF: Current Evidence Insufficient to Recommend For or Against Atrial Fibrillation Screening
In a new statement, the USPSTF determined current evidence is insufficient to recommend for or against screening for AF in older patients.
Shingles Vaccination Significantly Reduced Dementia Risk in Large Retrospective Cohort Study
In persons who received both the HZV and Tdap vaccines, a significant 50% reduction in risk of dementia was seen, suggesting a nonspecific underlying association.
Researchers in Japan Propose Criteria for Discontinuing Biologics in Patients with Severe Asthma
A team of researchers published proposed criteria for the discontinuation of biologics for patients with severe asthma that has been controlled.
Sleep Duration May Have Greater Cardiometabolic Impact on Women vs Men
Results of a new study that used early clinical surrogate markers of metabolic disease find women at greater risk related to suboptimal sleep.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of January 27, 2022
Primary Viewpoints Episode 13: Possible Consequences of a Prolonged COVID-19 Era
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with author and psychiatrist Samoon Ahmad, MD.
PrEP for HIV Prevention: A Guideline Update Topline
The CDC update recommends that clinicians advise all sexually active patients about PrEP and includes a new section on prescribing injectable bimonthly cabotegravir.
